Variant report
Variant | nsv441813 |
---|---|
Chromosome Location | chr3:24108071-24114939 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:24040191..24040792-chr3:24110416..24111055,2 | MCF-7 | breast: | |
2 | chr3:24110053..24112130-chr3:24113190..24114976,2 | MCF-7 | breast: | |
3 | chr3:23957818..23960523-chr3:24109243..24112140,2 | MCF-7 | breast: | |
4 | chr3:24110646..24111147-chr3:24190699..24191477,2 | K562 | blood: | |
5 | chr3:24110053..24112130-chr3:24113190..24114976,2 | MCF-7 | breast: | |
6 | chr3:24110281..24111164-chr3:24722093..24722774,3 | K562 | blood: | |
7 | chr3:24108403..24110217-chr3:24304127..24305953,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000197885 | chromatin interactions |
ENSG00000174748 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11920383 | chr3:24108075-24108076 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs73822696 | chr3:24108136-24108137 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs11924501 | chr3:24108137-24108138 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs148396897 | chr3:24108142-24108143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538195214 | chr3:24108301-24108302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202215757 | chr3:24108322-24108323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556715995 | chr3:24108329-24108330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs578118610 | chr3:24108345-24108346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188966454 | chr3:24108398-24108399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181034993 | chr3:24108420-24108421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553083182 | chr3:24108442-24108443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142581552 | chr3:24108482-24108483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185540376 | chr3:24108517-24108518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573010741 | chr3:24108526-24108527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72628141 | chr3:24108530-24108531 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs146458112 | chr3:24108539-24108540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564670281 | chr3:24108546-24108547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188690002 | chr3:24108555-24108556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143385957 | chr3:24108562-24108563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567047817 | chr3:24108563-24108564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534094456 | chr3:24108599-24108600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549656417 | chr3:24108629-24108630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575849457 | chr3:24108655-24108656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567932578 | chr3:24108679-24108680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538258796 | chr3:24108682-24108683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs180817327 | chr3:24108746-24108747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs578177809 | chr3:24108747-24108748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544590584 | chr3:24108806-24108807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561535111 | chr3:24108836-24108837 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572207154 | chr3:24108845-24108846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114555401 | chr3:24108868-24108869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146723192 | chr3:24108873-24108874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73822697 | chr3:24108914-24108915 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs543046091 | chr3:24108921-24108922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564671079 | chr3:24108922-24108923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564538896 | chr3:24108923-24108924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73134559 | chr3:24108961-24108962 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs11924778 | chr3:24108982-24108983 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs559139668 | chr3:24108998-24108999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533339061 | chr3:24109025-24109026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs62253449 | chr3:24109028-24109029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7612158 | chr3:24109112-24109113 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs549277796 | chr3:24109130-24109131 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567993948 | chr3:24109141-24109142 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186152198 | chr3:24109144-24109145 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550238786 | chr3:24109154-24109155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571676309 | chr3:24109182-24109183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560202913 | chr3:24109192-24109193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538607456 | chr3:24109286-24109287 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs554262075 | chr3:24109296-24109297 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24101400-24119200 | Weak transcription | Aorta | Aorta |
2 | chr3:24102200-24109200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr3:24102200-24110400 | Weak transcription | Colon Smooth Muscle | Colon |
4 | chr3:24105000-24110200 | Weak transcription | Rectal Smooth Muscle | rectum |
5 | chr3:24107600-24108800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr3:24108000-24108400 | Enhancers | Placenta | Placenta |
7 | chr3:24108800-24109200 | Enhancers | K562 | blood |
8 | chr3:24108800-24109400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr3:24108800-24109400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr3:24108800-24109400 | Enhancers | NHDF-Ad | bronchial |
11 | chr3:24108800-24115200 | Weak transcription | Right Ventricle | heart |
12 | chr3:24109000-24109200 | Enhancers | HSMM | muscle |
13 | chr3:24109200-24109600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr3:24109400-24110400 | Weak transcription | HSMM | muscle |
15 | chr3:24110200-24111000 | Enhancers | Rectal Smooth Muscle | rectum |
16 | chr3:24110400-24111000 | Enhancers | HSMM | muscle |
17 | chr3:24110400-24111600 | Enhancers | Colon Smooth Muscle | Colon |